ArticleRecent patents on anti-cancer drug discovery2025

Comprehensive Analysis and Experimental Validation of TLL2 as a Potential New Prognostic Biomarker Associated with Immune Infiltration in Lung Adenocarcinoma.

Jing Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.